# Innovation Pharmaceuticals Inc. (IPIX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/IPIX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2024 | $ 0 | $ -951.5K | $ -734.2K | $ 238.0K | $ 1.16M |
| 2023 | $ -6.5K | $ -3.46M | $ -2.34M | $ 268.0K | $ 2.04M |
| 2022 | $ 20.1K | $ -8.12M | $ -7.10M | $ 1.29M | $ 4.73M |
| 2021 | $ -723.9K | $ -16.49M | $ -11.37M | $ 1.87M | $ 7.51M |
| 2020 | $ 1.05M | $ -8.47M | $ -5.41M | $ 2.46M | $ 1.46M |
| 2019 | $ 0 | $ -11.21M | $ -8.28M | $ 1.92M | $ -4.13M |
| 2018 | $ 0 | $ -21.61M | $ -17.69M | $ 2.02M | $ -2.15M |
| 2017 | $ 0 | $ -20.93M | $ -16.23M | $ 2.02M | $ -1.46M |
| 2016 | $ 0 | $ -17.68M | $ -14.17M | $ 2.02M | $ 2.96M |
| 2015 | $ 0 | $ -18.46M | $ -19.00M | $ 2.02M | $ 7.02M |
| 2014 | $ 0 | $ -11.65M | $ -14.39M | $ 2.02M | $ 1.21M |
| 2013 | $ 82 | $ -4.59M | $ -2.72M | $ 4.04M | $ -5.17M |
| 2012 | $ 1.35M | $ -7.07M | $ -1.00M | $ 4.04M | $ -7.63M |
| 2011 | $ 0 | $ -8.72M | $ -1.08M | $ 516.3K | $ -7.29M |
| 2010 | $ 0 | $ -5.20M | $ -1.68M | $ 1.47M | $ -4.80M |
| 2009 | $ 0 | $ -2.25M | $ -320.2K | $ 432.3K | $ -1.79M |
| 2008 | $ 0 | $ -796.1K | $ -121.9K | $ 400.0K | $ -362.0K |
| 2007 | $ 0 | $ -72.9K | $ -9.0K | N/A | $ 18.7K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.20 |
| Liabilities / Eq | 4.74 |
| Current Ratio | 0.19 |

## Other views

- [Metrics](https://sponda.capital/en/IPIX.md)
- [Charts](https://sponda.capital/en/IPIX/charts.md)
- [Compare](https://sponda.capital/en/IPIX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.